Annual Drug Patent Expirations for QULIPTA
Qulipta is a drug marketed by Abbvie Inc and is included in one NDA. It is available from one supplier. There are four patents protecting this drug.
This drug has eigthy-four patent family members in forty-one countries.
The generic ingredient in QULIPTA is atogepant. One supplier is listed for this compound. Additional details are available on the atogepant profile page.
For more information on how DrugPatentWatch can help with your pharmaceutical business intelligence needs, contact admin@DrugPatentWatch.com or visit www.DrugPatentWatch.com
